Protection against lung damage in reduced-size liver transplantation

Critical Care Medicine

Volumn 34, Issue 5, 2006, Pages 1506-1513

  Franco Gou, Rosa ^a   Roselló Catafau, Joan ^a   Peralta, Carmen ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Interleukin 1; Ischemia reperfusion; Liver graft; Lung damage; Soluble tumor necrosis factor receptor; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1; NITRIC OXIDE; NITRIC OXIDE DONOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; IMMUNOGLOBULIN G; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; EXPERIMENTAL MODEL; LIVER GRAFT; LIVER PERFUSION; LIVER TRANSPLANTATION; LUNG INJURY; MALE; NONHUMAN; ORTHOPTICS; PRIORITY JOURNAL; PROTECTION; RAT; REDUCED SIZE LIVER TRANSPLANTATION; REPERFUSION INJURY; RISK BENEFIT ANALYSIS; ANIMAL; EVALUATION; ISCHEMIC PRECONDITIONING; LUNG; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; IMMUNOGLOBULIN G; INTERLEUKIN-1; ISCHEMIC PRECONDITIONING; LIVER TRANSPLANTATION; LUNG; MALE; NITRIC OXIDE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646563710     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000215512.68930.A8     Document Type: Article

References (45)

1. Peralta C, Bulbena O, Xaus C, et al: Ischemic preconditioning: A defense mechanism against the reactive oxygen species generated after hepatic ischemia reperfusion. Transplantation 2002; 73:1203-1211
2. Fernandez L, Heredia N, Grande L, et al: Preconditioning protects liver and lung damage in rat liver transplantation: Role of xanthine/xanthine oxidase. Hepatology 2002; 36: 562-572
3. Peralta C, Bulbena O, Bargallo, et al: Strategies to modulate the deleterious effects of endothelin in hepatic ischemia-reperfusion. Transplantation 2000; 70:1761-1770
4. Peralta C, Prats N, Xaus C, et al: Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat. Hepatology 1999; 30:1481-1489
5. Peralta C, Fernandez L, Panes J, et al: Pre-conditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology 2001; 33:100-113
6. Franco-Gou R, Peralta C, Massip-Salcedo M, et al: Protection of reduced-size liver for transplantation. Am J Transplant 2004; 4:1408-1420
7. Liu P, Xu B, Hock CE: Inhibition of nitric oxide synthesis by L-name exacerbates acute lung injury induced by hepatic ischemia-reperfusion. Shock 2001; 16:211-217
8. Hato S, Urakami A, Yamano T, et al: Attenuation of liver and lung injury after hepatic ischemia and reperfusion by a cytokine-suppressive agent, FR167653. Eur Surg Res 2001; 33:202-209
9. Wanner GA, Ertel W, Muller P, et al: Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock 1996; 5:34-40
10. Watanabe M, Yamaguchi K, Chijiiwa K, et al: FR167653 improves survival and pulmonary injury after partial hepatectomy under ischemia/reperfusion in rats. J Surg Res 2001; 101:146-151
11. Liu P, Xu B, Spokas E, et al: Role of endogenous nitric oxide in TNF-alpha and IL-1beta generation in hepatic ischemia-repefusion. Shock 2000; 13:217-223
12. Liu P, Xu B, Hock CE: Inhibition of nitric oxide synthesis by L-name exacerbates acute lung injury induced by hepatic ischemia-reperfusion. Shock 2001; 16:211-217
13. Serafin A, Rosello-Catafau J, Prats N, et al: Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology 2004; 39: 688-698
14. Kim YM, Talanian RV, Li J, et al: Nitric oxide prevents IL-1beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1beta-converting enzyme). J Immunol 1998; 161:4122-4128
15. Shito M, Wakabayashi G, Ueda M, et al: Interleukin 1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat. Transplantation 1997; 63: 14314-14318
16. Seekamp A, Warren JS, Remick DG, et al: Requirements for tumor necrosis factor-alpha and interleukin-1 in limb ischemia/ reperfusion injury and associated lung injury. Am J Pathol 1993; 143:453-463
17. Grenz A, Schenk M, Zipfel A, et al: TNF-alpha and its receptors mediate graft rejection and loss after liver transplantation. Clin Chem Lab Med 2000; 38:1183-1185
18. Weil D: What's new about tumor necrosis factors? Report on the fourth TNF International Congress. Eur Cytokine Netw 1992; 3:347-351
19. Leist M, Gantner F, Jilg S, et al: Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 1995; 154:1307-1316
20. Niederle N, Ganser A, Bergmann L: Zytokine. Jena, Gustav Fischer Verlag, 1996, 15-19
21. Lin SY, Wang YY, Sheu WH: Increased serum leptin concentrations correlate with soluble tumour necrosis factor receptor levels in patients with cirrhosis. Clin Endocrinol (Oxf) 2002; 57:805-811
22. Majno PE, Morel P, Mentha G: Mini-review: Tumor necrosis factor (TNF) and TNF soluble receptors (TNF-sR) in liver disease and liver transplantation. Swiss Surg 1995; (4): 182-185.
23. on Baehr V, Docke WD, Plauth M, et al: Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: Role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation. Gut 2000; 47:281-287
24. Fulop AK, Pocsik E, Brozik M, et al: Hepatic regeneration induces transient acute phase reaction: Systemic elevation of acute phase reactants and soluble cytokine receptors. Cell Biol Int 2001; 25:585-592
25. Carney DE, Lutz CJ, Picone AL, et al: Soluble tumor necrosis factor receptor prevents post-pump syndrome. J Surg Res 1999; 83:113-121
26. Sorkine P, Setton A, Halpern P, et al: Soluble tumor necrosis factor receptors reduce bowel ischemia-induced lung permeability and neutrophil sequestration. Crit Care Med 1995; 23:1377-1381
27. Holtmann H, Wallach D: Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate. J Immunol 1987; 139:1161-1167
28. Winzen R, Wallach D, Kemper O, et al: Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1. J Immunol 1993; 150: 4346-4353
29. Hart PH, Hunt EK, Bonder CS, et al: Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10. J Immunol 1996; 157:3672-3680
30. Kamada N, Calne RY: Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979; 28:47-50
31. Hinz B, Schroder H: Nitrate tolerance is specific for nitric acid esters and its recovery requires an intact protein synthesis. Biochem Biophys Res Commun 1998; 252:232-235
32. Homer KL, Fiore SA, Wanstall JC: Inhibition by 1H-[1,2,4]oxadiazolo[4,3- a]quinoxalin-1-one (ODQ) of responses to nitric oxide-donors in rat pulmonary artery: Influence of the mechanism of nitric oxide generation. J Pharm Pharmacol 1999; 51:135-139
33. Eleftheriadis E, Kotzampassi K, Papanotas K, et al: Gut ischemia, oxidative stress, and bacterial translocation in elevated abdominal pressure in rats. World J Surg 1996; 20:11-16
34. Cuzzocrea S, Mazzon E, Di Paola R, et al: Protective effect of M40401, a selective superoxide dismutase mimetic, on zymosan-induced nonseptic shock. Crit Care Med 2004; 32:156-167
35. Schmekel B, Karlsson SE, Linden M, et al: Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity Inflammation 1990; 14:447-454
36. Chen LW, Wang JS, Chen HL, et al: Peroxynitrite is an important mediator in thermal injury-induced lung damage. Crit Care Med 2003; 31:2170-2177
37. Kermarrec N, Selloum S, Plantefeve G, et al: Regulation of peritoneal and systemic neutrophil-derived tumor necrosis factor-α release in patients with severe peritonitis: Role of tumor necrosis factor-α converting enzyme cleavage. Crit Care Med 2005; 33:1359-1364
38. Cortijo J, Cerda-Nicolas M, Serrano A et al: Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. Eur Respir J 2001; 17:1228-1235
39. Yassin MM, Harkin DW, Barros D'Sa AA, et al: Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction. World J Surg 2002; 26:115-121
40. Malik R, Selden C, Hodgson H: The role of non-parenchymal cells in liver growth. Semin Cell Dev Biol 2002; 13:425-431
41. Colletti LM, Remick DG, Burtch GD, et al: Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990; 85:1936-1943
42. Jaeschke H, Farhood A: Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 1991; 260:G355-G362
43. Zheng SS, Xu SG, Liang TB, et al: Early expression of pro-inflammatory cytokines in the lung of rat with small-for-size liver transplantation and the significance Zhonghua Yi Xue Za Zhi 2003; 83:588-592
44. Beutler B, Milsark IW, Cerami AC: Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229:869-871
45. Ertel W, Scholl FA, Gallati H, et al: Increased release of soluble tumor necrosis factor receptors into blood during clinical sepsis. Arch Surg 1994; 129:1330-1337